arrow
E

Elena Ongaro

centro di riferimento oncologico aviano
H指数:23
被引数:2,332

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Probe-Based Confocal Laser Endomicroscopy During Immune Checkpoint Inhibitor Therapy: A Translational Framework Linking Intestinal Barrier Function, Microbiota, and Clinical Outcomes

基于探针的共聚焦激光内窥镜在免疫检查点抑制剂治疗期间的应用:连接肠道屏障功能、微生物组和临床结局的转化研究框架

2026-09-210
OA
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection

吉西他滨联合 nab-紫杉醇后转移性胰腺癌的二线化疗:比较结果及人工智能指导的治疗选择

2026-04-010
PRE
HLA-G alleles in Italian patients with locally advanced rectal cancer (LARC)

意大利局部晚期直肠癌(LARC)患者中的HLA-G等位基因

2026-02-070
PRE
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study

一项关于吉西他滨和 Nab-Paclitaxel 作为换用维持治疗 versus 改良 FOLFIRINOX 作为一线化疗在晚期胰腺癌患者中的随机 III 期临床试验:PANThEON 研究

2025-11-280
PRE
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy

微卫星稳定型结直肠癌中高肿瘤突变负荷的基因组分析揭示了抗-EGFR治疗后MAPK信号通路的改变

2025-10-280
OAAI
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: an individual patient data-based pooled analysis of randomized trials

FOLFOXIRI/bevacizumab与双药/bevacizumab作为不可切除的肝-only、右侧和/或RAS或BRAF突变转移性结直肠癌初始治疗的比较:一项基于个体患者数据的随机试验合并分析

2025-08-150
PRE
FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable liver-only (LL), right-sided and/or RAS or BRAF mutated (mut) metastatic colorectal cancer (mCRC): An individual patient data-based pooled analysis of randomized trials

FOLFOXIRI/贝伐单抗 (bev) 与双药/bev作为不可切除的肝脏 (LL),右侧和/或RAS或BRAF突变 (mut) 转移性结直肠癌 (mCRC) 的初始治疗: 基于个体患者数据的随机试验汇总分析

2024-06-010
PRE
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives

边界可切除和局部晚期胰腺癌的术前治疗: 当前证据和新观点

2023-06-014
PRE
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study
2021-01-0125
PREAI
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
2020-05-057
OAAI
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study

V600EBRAF-mutated转移性结直肠癌的有效预后分类器: 'BRAF BeCool' 研究

2019-09-0158
OAAI